Jörg Trojan
Gastroenterologe,
Internist,
Onkologe
Geboren:
1969
Hat mitgewirkt an:
-
Understanding the patient experience in hepatocellular carcinoma: a qualitative patient interview study
-
Sorafenib : aktuelle Therapieoptionen bei hepatozellulärem Karzinom
-
Understanding the patient experience in hepatocellular carcinoma: a qualitative patient interview study
-
Chemotherapy and Targeted Therapy Strategies in Patients with Unresectable or Borderline Resectable Metastatic Colorectal Cancer: Evidence for a Lack of Focus on Resection Rates